Emtricitabine
Emtriva (emtricitabine) is a small molecule pharmaceutical. Emtricitabine was first approved as Emtriva on 2003-07-02. It is used to treat HIV infections in the USA. It has been approved in Europe to treat HIV infections. Emtriva's patent is valid until 2021-03-09 (FDA).
| Trade Name | Emtriva |
|---|---|
| Common Name | Emtricitabine |
| Indication | hiv infections |
| Drug Class | Nucleoside antiviral or antineoplastic agents, cytarabine or azarabine derivatives |
